ACTAVIS SUBUTEX - AN OVERVIEW

After stopping a CYP3A4 inducer, because the effects on the inducer decline, the buprenorphine plasma focus will enhance [see CLINICAL PHARMACOLOGY], which could maximize or prolong both equally therapeutic effects and adverse reactions and should cause significant respiratory depression.Serotonin syndrome: Conditions of serotonin syndrome, a likel